Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02609685 · ClinicalTrials.gov registry record · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
A NA study of Papillary Thyroid Microcarcinoma, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT02609685: Recruiting NA study of Papillary Thyroid Microcarcinoma, sponsored by Cedars-Sinai Medical Center.
NCT02609685 is a NA study of Papillary Thyroid Microcarcinoma that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02609685, a NA study of Papillary Thyroid Microcarcinoma, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand the outcomes of active surveillance (observation) instead of immediate surgery, which is the current standard of care for papillary thyroid microcarcinoma (PTMC). Patients with a 1.5 cm or smaller thyroid nodule(s) with papillary thyroid carcinoma will be eligible for the study.
Conditions Studied
Interventions
- OTHER Active Surveillance
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2016-05-13 |
| Est. Completion | 2030-12 |
| Phase | NA |
What NCT02609685 shows while recruiting
NCT02609685 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Papillary Thyroid Microcarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Active Surveillance is the first listed.
NCT02609685 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02609685 about?
NCT02609685 is a clinical study titled "Active Surveillance of Papillary Thyroid Microcarcinoma". The purpose of this study is to better understand the outcomes of active surveillance (observation) instead of immediate surgery, which is the current standard of care for papillary thyroid microcarcinoma (PTMC). Patients with a 1.5 cm or smaller thyroid nodule(s) with papillary thyroid carcinoma wi...
What is the current status of trial NCT02609685?
This trial is currently recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2016-05-13. Estimated completion is 2030-12.
What conditions does trial NCT02609685 study?
This clinical trial studies the following conditions: Papillary Thyroid Microcarcinoma.
What interventions are being tested in trial NCT02609685?
The interventions under investigation include: Active Surveillance (OTHER).
Who is sponsoring clinical trial NCT02609685?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02609685 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papillary Thyroid Microcarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02609685's enrollment target sits among peer trials
216 485th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
- NCT05616312 · 216 participants · NA
Patient Recall After Orthopedic Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI